[DPHARMA] Audit Committee REDESIGNATION - ENCIK RAZALEE BIN AMIN on 01-Sep-2016

Stock
[DPHARMA] : DUOPHARMA BIOTECH BERHAD
Announcement Date
01-Sep-2016
Audit Committee Information:
Date of Change
01-Sep-2016
Type of Change
REDESIGNATION
Designation
Audit Committee
Directorate
Independent and Non Executive
Name
ENCIK RAZALEE BIN AMIN
Age
62
Gender
Male
Nationality
Malaysia
Composition
1. Encik Razalee bin Amin - Chairman of Audit & Risk Management Committee
2. Dato' Mohamad Kamarudin bin Hassan - Member of Audit & Risk Management Committee
3. Puan Zaiton binti Jamaluddin - Member of Audit & Risk Management Committee
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment